Home

Braslyn Ltd.

CIK 1642355 · last filed 2024-01-25

Braslyn Ltd. is a corporate insider who has filed 22 SEC Form 4 insider transactions across 3 companies since 2016. Across all open-market trades the lifetime net is −$228.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.39M

Companies

3

Total Filings

22

Lifetime Open-Market Net

-$228.18M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Mirati Therapeutics, Inc. (MRTX) Delisted 10%+ Owner 3,135,557 $58.70 $184.06M -$269.37M 19 2021-03-10
INSG 10%+ Owner 761,483 $7.08 $5.39M -$36.81M 1 2020-12-16
Pandion Therapeutics, Inc. (PAND) Delisted 10%+ Owner 1,408,913 $60.05 $84.61M $78.00M 1 2020-07-21

Recent Filings

22 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-01-25 — Disp (D) −61,735,896 $0
2021-03-10 Mirati Therapeutics, Inc. (MRTX) Delisted Mixed — -$4.89M EDGAR
2020-12-16 INSG Sell (S) −2,385,170 -$36.81M EDGAR
2020-10-30 Mirati Therapeutics, Inc. (MRTX) Delisted Mixed — -$166.67M EDGAR
2020-07-21 Pandion Therapeutics, Inc. (PAND) Delisted Mixed +12,786,810 $78.00M EDGAR
2020-06-16 Mirati Therapeutics, Inc. (MRTX) Delisted Mixed — -$58.20M EDGAR
2020-06-16 Mirati Therapeutics, Inc. (MRTX) Delisted Mixed — -$41.40M EDGAR
2019-03-05 Mirati Therapeutics, Inc. (MRTX) Delisted Mixed — -$18.98M EDGAR
2017-11-20 Mirati Therapeutics, Inc. (MRTX) Delisted Buy (P) +800,000 $10.40M EDGAR
2017-01-30 Mirati Therapeutics, Inc. (MRTX) Delisted Buy (P) +48,169 $262.3K EDGAR
Showing 1–10 of 22
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.